Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma

Journal of Clinical Oncology

Volumn 24, Issue 10, 2006, Pages 1561-1567

  Richards, William G ^a   Zellos, Lambros ^a   Bueno, Raphael ^a   Jaklitsch, Michael T ^a   Jänne, Past A ^a   Chirieac, Lucian R ^a   Yeap, Beow Y ^a   Dekkers, Rene J ^a   Hartigan, Phillip M ^a   Capalbo, Leah ^a   Sugarbaker, David J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; SODIUM THIOSULFATE;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECORTICATION; DEEP VEIN THROMBOSIS; DOSE RESPONSE; DRUG DOSE ESCALATION; HEART ATRIUM FIBRILLATION; HUMAN; ILEUS; LOW DRUG DOSE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MULTIPLE ORGAN FAILURE; NEPHROTOXICITY; PEROPERATIVE CARE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PLEURA MESOTHELIOMA; PLEURECTOMY; PNEUMONIA; PRIORITY JOURNAL; RECURRENT DISEASE; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY FAILURE; FEMALE; HYPERTHERMIC THERAPY; MALE; MAXIMUM TOLERATED DOSE; MESOTHELIOMA; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PLEURA; PLEURA TUMOR; PROSPECTIVE STUDY; TREATMENT FAILURE;

AGED; AGED, 80 AND OVER; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MALE; MAXIMUM TOLERATED DOSE; MESOTHELIOMA; MIDDLE AGED; PLEURA; PLEURAL NEOPLASMS; PROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 33645736980     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.04.6813     Document Type: Article

References (27)

1. Merritt N, Blewett CJ, Miller JD, et al: Survival after conservative (palliative) management of pleural malignant mesothelioma. J Surg Oncol 78:171-174, 2001
2. Vogelzang NJ, Rusthoven JJ, Symanowski J, et al: Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21: 2636-2644, 2003
3. Sugarbaker DJ, Flores RM, Jaklitsch MT, et al: Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients. J Thorac Cardiovasc Surg 117:54-63, 1999
4. Soysal O, Karaoglanoglu N, Demiracan S, et al: Pleurectomy/decortication for palliation in malignant pleural mesothelioma: Results of surgery. Eur J Cardiothorac Surg 11:210-213, 1997
5. Martin-Ucar AE, Edwards JG, Rengajaran A, et al: Palliative surgical debulking in malignant mesothelioma: Predictors of survival and symptom control. Eur J Cardiothorac Surg 20:1117-1121, 2001
6. Sugarbaker PH, Acherman YIZ, Gonzalez-Moreno S, et al: Diagnosis and treatment of peritoneal mesothelioma: The Washington Cancer Institute Experience. Semin Oncol 29:51-61, 2002
7. Sugarbaker PH: Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol 14:254-261, 1998
8. Rey Y, Porcheron J, Talabard JN, et al: Carcinoses peritoneales traitees par chirurgie de reduction tumorale et chimiohyperthermie intraperitoneale. Ann Chir 125:631-642, 2000
9. van der Vange N, van Goethem AR, Zoetmulder FA, et al: Extensive cytoreductive surgery combined with intra-operative intraperitoneal perfusion with cisplatin under hyperthermic conditions (OVHIPEC) in patients with recurrent ovarian cancer: A feasibility pilot. Eur J Surg Oncol 26:663-668, 2000
10. Elias D, Blot F, El Otmany A, et al: Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 92:71-76, 2001
11. Kodama K, Osamu D, Tatsuta M, et al: Development of postoperative intrathoracic chemothermotherapy for lung cancer with objective of improving local cure. Cancer 64:1422-1428, 1989
12. Carry PY, Brachet A, Gilly FN, et al: A new device for the treatment of pleural malignancies: Intrapleural chemohyperthermia preliminary report. Oncology 50:348-352, 1993
13. Matsuzaki Y, Shibata K, Yoshioka M, et al: Intrapleural perfusion hyperthermo-chemotherapy for malignant pleural dissemination and effusion. Ann Thorac Surg 59:127-131, 1995
14. Ratto GB, Civalleri D, Esposito M, et al: Pleural space perfusion with cisplatin in the multimodality treatment of malignant mesothelioma: A feasibility and pharmacokinetic study. J Thorac Cardiovasc Surg 117:759-765, 1999
15. Howell SB, Taetle R: Effect of sodium thiosulfate on cis- dichlorodiammineplatinum(II) toxicity and antitumor activity in L1210 leukemia. Cancer Treat Rep 64:611-616, 1980
16. Markman M, Cleary S, Howell SG: Nephrotoxicity of high-dose intracavitary cisplatin with intravenous thiosulfate protection. Eur J Cancer Clin Oncol 21:1015-1018, 1985
17. Rusch V, Saltz L, Venkatraman E, et al: A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. J Clin Oncol 12:1156-1163, 1994
18. Colleoni M, Sartori F, Calabro F, et al: Surgery followed by intracavitary plus systemic chemotherapy in malignant pleural mesothelioma. Tumori 82: 53-56, 1996
19. Sugarbaker DJ, Mentzer SJ, Strauss G: Extrapleural pneumonectomy in the treatment of malignant, pleural mesothelioma. Ann Thorac Surg 54: 941-946, 1992
20. National Cancer Institute: Common Toxicity Criteria Manual, Version 2.0. Bethesda, MD, National Cancer Institute, 1999
21. Pass HI, Kranda K, Temeck BK, et al: Surgically debulked malignant pleural mesothelioma: Results and prognostic factors. Ann Surg Oncol 4:215-222, 1997
22. Lee JD, Perez S, Wang HJ, et al: Intrapleural chemotherapy for patients with incompletely resected malignant mesothelioma: The UCLA experience. J Surg Oncol 60:262-267, 1995
23. Lu C, Perez-Soler R, Piperdi B, et al: Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma. J Clin Oncol 23:3495-3501, 2005
24. Antman KH, Corson JM, Li FP, et al: Malignant mesothelioma following radiation exposure. J Clin Oncol 1:695-700, 1983
25. Take H, Kubota K, Tamura K, et al: Activation of circulating platelets by hyperthermal stress. Eur J Med Res 1:562-564, 1996
26. Pivalizza EG, Koch SM, Mehlhom U, et al: The effects of intentional hyperthermia on the Thrombelastograph and Sonoclot analyser. Int J Hyperthermia 15:217-223, 1999
27. Tamura K, Kubota K, Kurabayashi H, et al: Effects of hyperthermal stress on the fibrinolytic system. Int J Hyperthermia 12:31-36, 1996